The Current Ratio as of December 2024 (TTM) for Pasithea Therapeutics Corp. (KTTA) is 14.81

According to Pasithea Therapeutics Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 14.81. This represents a change of 81.20% compared to the average of 8.17 of the last 4 quarters.

Pasithea Therapeutics Corp. (KTTA) Historical Current Ratio (quarterly & annually)

How has KTTA Current Ratio performed in the past?

The mean historical Current Ratio of Pasithea Therapeutics Corp. over the last ten years is 45.30. The current 14.81 Current Ratio has changed 3.17% with respect to the historical average. Over the past ten years (40 quarters), KTTA's Current Ratio was at its highest in in the December 2021 quarter at 119.17. The Current Ratio was at its lowest in in the September 2020 quarter at 0.

Pasithea Therapeutics Corp. (KTTA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Pasithea Therapeutics Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pasithea Therapeutics Corp. (KTTA) Average Current Ratio

How has KTTA Current Ratio performed in the past?

The current Current Ratio of Pasithea Therapeutics Corp. (KTTA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Pasithea Therapeutics Corp. (KTTA) Current Ratio vs. Peers

How is KTTA’s Current Ratio compared to its peers?

Pasithea Therapeutics Corp.’s Current Ratio is greater than Nutriband Inc. (4.96), greater than ZIVO Bioscience, Inc. (0.17), less than MediciNova, Inc. (16.66), less than Eliem Therapeutics, Inc. (0), less than Virax Biolabs Group Limited (25.94), greater than Blue Water Vaccines, Inc. (0.06), greater than Revelation Biosciences, Inc. (1.64), greater than Hillstream BioPharma, Inc. (2.25), greater than Kiora Pharmaceuticals, Inc. (8.97), greater than Kezar Life Sciences, Inc. (7.65), greater than Kronos Bio, Inc. (8.32), greater than Quoin Pharmaceuticals, Ltd. (3.02), greater than RenovoRx, Inc. (5.66), greater than ABVC BioPharma, Inc. (0.34), greater than Indaptus Therapeutics, Inc. (3.42), greater than Better Therapeutics, Inc. (0.57), greater than Forte Biosciences, Inc. (2.06), greater than PaxMedica, Inc. Common Stock (0.38),

Build a custom stock screener for Pasithea Therapeutics Corp. (KTTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pasithea Therapeutics Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pasithea Therapeutics Corp. (KTTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pasithea Therapeutics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.